Lifgemci 1.4 g

Rx — Prescription only Oncology Injectable / Vial

Cytotoxic chemotherapy, an antimetabolite, presented as a lyophilized powder for solution.

Composition

Gemcitabine Injection 1.4 g

Strength

1.4 g / Vial

Pack size

1 Vial

Therapeutic category

Oncology

Indications

Lung Cancer, Breast Cancer, Pancreatic Cancer, Ovarian Cancer

Dosage and directions

For intravenous use. To be prescribed, dosed and administered under the supervision of a qualified oncologist. Refer to the approved pack insert for the full prescribing information.

Marketed by

LifeSpark Pharma Private Limited

Manufactured at WHO-GMP approved partner facilities. The manufacturing plant and licence number are printed on the pack.

Keep out of reach of children. Products to be used as directed. Read the label carefully. Consult your physician. To be sold by retail on the prescription of a registered medical practitioner only.

This page is a summary. The pack insert supplied with the product is the authoritative document; where the two differ, the insert prevails. Experienced a side effect? Report it here.

Others in Oncology

Palbocilif 75 mg

Palbociclib 75 mg

1 x 28 Capsules

Palbocilif 100 mg

Palbociclib 100 mg

1 x 28 Capsules

Palbocilif 125 mg

Palbociclib 125 mg

1 x 28 Capsules

Enquire about Lifgemci 1.4 g

Please mention the quantity or the information you need. For side effects, use the pharmacovigilance form instead.

Full name

Organisation / Firm

Phone

City / District

Subject

Your enquiry

I agree that LifeSpark Pharma may contact me about this enquiry, and I have read the Privacy Policy.

Fields marked * are required.

This form is for business and product information only. To report a side effect or a product complaint, please use the pharmacovigilance form so it reaches the right team.